Trial intelligence / Profile preview

Bioavailability of Dronabinol Oral Solution vs Marinol in Healthy Volunteers

NCT02604992Phase 1Completed

Sponsor
Insys Therapeutics
Start
Nov 2015
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of dronabinol in anorexia nervosa (AN), nausea ((none)) and Vomiting (6 arms), sponsored by Insys Therapeutics. Primary endpoints: Area under the curve from time 0 to the last measured concentration, Area under the curve extrapolated to infinity and 7 more. Started Nov 2015; status: completed.

02

Drugs

dronabinol
03

Conditions

anorexia nervosa (AN)nausea ((none))Vomiting

Beyond the preview

Go deeper on NCT02604992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02604992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call